info@synchemia.com | sales@synchemia.com 
9766925136 
Atorvastatin
Atorvastatin | CAS NO: 134523-00-5, Lowering Cholesterol: It helps reduce levels of low-density lipoprotein (LDL) cholesterol and total cholesterol, which can help prevent cardiovascular disease. Reducing Cardiovascular Risk: It’s often prescribed to lower the risk of heart attack and stroke in individuals with high cholesterol or those with risk factors for heart disease. Managing Dyslipidemia: Atorvastatin is used to treat conditions characterized by abnormal lipid levels, including hyperlipidemia and mixed dyslipidemia. Improving Lipid Profiles: It can help raise high-density lipoprotein (HDL) cholesterol levels, which is considered beneficial for heart health.
We are the Synchemia Research Chemical specializes in manufacturing and supplying of Atorvastatin impurities that meet specific pharmacopeial standards (EP/BP/USP/IP) as well as process-related impurities Preventing Atherosclerosis: It may also be used to slow the progression of atherosclerosis in certain patients. As with any medication, it's important to discuss with a healthcare provider to understand its benefits and potential side effects. Buy Reliable and High-Purity Atorvastatin Impurities, Delivered by Synchemia Research Chemicals.
Download catalogue
Pharmaceutical Reference Standards
| CAT No | SRC-A121 |
| CAS No | 344423-98-9 |
| Mol.F. | C33H34FN2O5 : 1/2(Ca) : 3/2H2O |
| Mol.Wt. | 557.6 : 1/2(40.1) : 3/2(18.0) g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-A122 |
| CAS No | 1516864-05-3 |
| Mol.F. | C33H35N2O5 : Na |
| Mol.Wt. | 539.7 : 23.0 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-A123 |
| CAS No | 842103-12-2 |
| Mol.F. | C33H35FN2O5 |
| Mol.Wt. | 558.7 g/mol |
| INV STATUS | IN STOCK |
| CAT No | SRC-A124 |
| CAS No | 693793-53-2 |
| Mol.F. | C33H34F2N2O5 : 1/2(Ca) |
| Mol.Wt. | 576.6 : 1/2(40.1) g/mol |
| INV STATUS | IN STOCK |
| CAT No | SRC-A125 |
| CAS No | 148146-51-4 |
| Mol.F. | C26H22FNO4 |
| Mol.Wt. | 431.5 g/mol |
| INV STATUS | IN STOCK |
| CAT No | SRC-A126 |
| CAS No | 1428118-38-0 |
| Mol.F. | C33H34FN2O5 : Na |
| Mol.Wt. | 557.6 : 23.0 g/mol |
| INV STATUS | IN STOCK |
| CAT No | SRC-A127 |
| CAS No | 887196-24-9 |
| Mol.F. | C40H48FN3O8 |
| Mol.Wt. | 717.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-A128 |
| CAS No | 887196-29-4 |
| Mol.F. | C34H36FN2O5 : 1/2(Ca) |
| Mol.Wt. | 571.7 : 1/2(40.1) g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-A129 |
| CAS No | 125995-03-1 |
| Mol.F. | C33H33FN2O4 |
| Mol.Wt. | 540.6 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-A130 |
| CAS No | 125971-95-1 |
| Mol.F. | C40H47FN2O5 |
| Mol.Wt. | 654.8 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-A131 |
| CAS No | 1105067-93-3 |
| Mol.F. | C33H33FN2O4 |
| Mol.Wt. | 540.6 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-A132 |
| CAS No | 345891-62-5 |
| Mol.F. | C34H37FN2O5 |
| Mol.Wt. | 572.7 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-A133 |
| CAS No | 1146977-93-6 |
| Mol.F. | C35H39FN2O5 |
| Mol.Wt. | 586.7 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-A134 |
| CAS No | 134395-00-9 |
| Mol.F. | C37H43FN2O5 |
| Mol.Wt. | 614.9 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-A135 |
| CAS No | 906552-19-0 |
| Mol.F. | C33H33FN2O5 |
| Mol.Wt. | 556.6 g/mol |
| INV STATUS | IN STOCK |
| CAT No | SRC-A136 |
| CAS No | 1795791-15-9 |
| Mol.F. | C33H31FN2O5 |
| Mol.Wt. | 556.6 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
Let’s advance your research together.
Partner with us for specialized chemical materials and synthesis services that enable pharmaceutical innovation.
